Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.

Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351

Purification and Characterization of Mouse Hematopoietic Stem Cells

Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988) · Science · doi:10.1126/science.2898810 · Cited by 2,908

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis

Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingPreprint

Lomaga, M. A., Yeh, W., Sarosi, I., Duncan, G. S., Furlonger, C. L., Ho, A. P., Morony, S., Capparelli, C., Van, G. Y., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,265

Osteoporosis: From osteoscience to neuroscience and beyond

Kwan, P. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.02.001 · Cited by 20

Osteoclast differentiation during experimental tooth movement by a short-term force application: An immunohistochemical study in rats

Xie, R., Kuijpers‐Jagtman, A. M., & Maltha, J. C. (2008) · Acta Odontologica Scandinavica · doi:10.1080/00016350802317488 · Cited by 20

Metabolic Bone Disease

Lorenzo, J. A., CANALIS, E. M., & Raisz, L. G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00029-8 · Cited by 20

Perspective on the Osteoclast

Cackowski, F. C., & Roodman, G. D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.073 · Cited by 20

Urolithin B suppresses osteoclastogenesis via inhibiting RANKL‐induced signalling pathways and attenuating ROS activities

Qu, Z., An, H., Feng, M., Huang, W., Wang, D., Zhang, Z., & Yan, L. W. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17467 · Cited by 20

Class A scavenger receptor promotes osteoclast differentiation via the enhanced expression of receptor activator of NF-κB (RANK)

Takemura, K., Sakashita, N., Fujiwara, Y., Komohara, Y., Lei, X., Ohnishi, K., Suzuki, H., Kodama, T., Mizuta, H., & Takeya, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.126 · Cited by 19

Anacardic acid inhibits RANKL‐induced osteoclastogenesis in vitro and prevents ovariectomy‐induced bone loss in vivo

Zhao, K., Jia, Y., Peng, J., Pang, C., Zhang, T., Han, W., Jiang, J., Lu, X., Zhu, J., & Qian, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201802575rr · Cited by 20

Nepetin inhibits osteoclastogenesis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signalling pathway, and autophagy

Chu, B., Chen, S., Zheng, X., Ye, J., Cheng, X., Zhang, L., Guo, D., Wang, P., Hong, D., & Hong, Z. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16055 · Cited by 19

Helvolic acid attenuates osteoclast formation and function via suppressing RANKL‐induced NFATc1 activation

Chen, K., Yuan, Y. J., Wang, Z., Song, D., Zhao, J., Cao, Z., Chen, J., Guo, Q., Chen, L., Tickner, J. C., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27385 · Cited by 20

Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor

Yamada, N., Tsujimura, T., Ueda, H., Hayashi, S., Ohyama, H., Okamura, H., & Terada, N. (2005) · Cytokine · doi:10.1016/j.cyto.2005.03.009 · Cited by 19

Human T-Cell Leukemia Virus Type I

Matsuoka, M. (2006) · Elsevier eBooks · doi:10.1016/b978-0-7216-0081-9.50033-9 · Cited by 19

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation

Qu, H., Zhuang, Y., Zhu, L., Zhao, Z., & Wang, K. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-7607 · Cited by 18

Osteoclast differentiation and recruitment during early stages of experimental tooth movement in rats

Xie, R., Kuijpers‐Jagtman, A. M., & Maltha, J. C. (2009) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2008.00588.x · Cited by 18

The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells

Lorenzo, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00009-8 · Cited by 20

Dietary zinc deficiency induces oxidative stress and promotes tumor necrosis factor-α- and interleukin-1β-induced RANKL expression in rat bone

Suzuki, T., Katsumata, S.-I., Matsuzaki, H., & Suzuki, K. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-87 · Cited by 18

Disruption of c-Kit Signaling in KitW-sh/W-sh Growing Mice Increases Bone Turnover

Lotinun, S., & Krishnamra, N. (2016) · Scientific Reports · doi:10.1038/srep31515 · Cited by 18

Picroside II Inhibits RANKL‐Mediated Osteoclastogenesis by Attenuating the NF‐κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice

Yang, X., Gao, W., Wang, B., Wang, X., Guo, H., Yuan, X. H., Kong, L., & Hao, D. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26105 · Cited by 19

Pmepa1 induced by RANKL‐p38 MAPK pathway has a novel role in osteoclastogenesis

Funakubo, N., Xu, X., Kukita, T., Nakamura, S., Miyamoto, H., & Kukita, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26147 · Cited by 18

Gene Expression Profiling of NFATc1-Knockdown in RAW 264.7 Cells: An Alternative Pathway for Macrophage Differentiation

Russo, R., Mallia, S., Zito, F., & Lampiasi, N. (2019) · Cells · doi:10.3390/cells8020131 · Cited by 18

PI3K activation increases SDF-1 production and number of osteoclast precursors, and enhances SDF-1-mediated osteoclast precursor migration

Adapala, N. S., Root, S. H., Lorenzo, J. A., Aguila, H. L., & Sanjay, A. (2019) · Bone Reports · doi:10.1016/j.bonr.2019.100203 · Cited by 18

Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone Resorption

Rauwel, B., Degboé, Y., Diallo, K., Sayegh, S., Baron, M., Boyer, J., Constantin, A., Cantagrel, A. G., & Davignon, J. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3943 · Cited by 18

Altered Hematopoietic Stem Cell and Osteoclast Precursor Frequency in Cathepsin K Null Mice

Jacome-Galarza, C. E., Soung, D. Y., Adapala, N. S., Pickarski, M., Sanjay, A., Duong, L. T., Lorenzo, J., & Drissi, H. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24801 · Cited by 18

Serum amyloid A inhibits RANKL-induced osteoclast formation

Oh, E., Lee, H. Y., Kim, H. J., Park, Y. J., Seo, J. K., Park, J. S., & Bae, Y. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.83 · Cited by 18

Human scaphoid non‐unions exhibit increased osteoclast activity compared to adjacent cancellous bone

Schira‐Heinen, J., Schulte, M., Döbele, C., Wallner, C., Abraham, S. L., Daigeler, A., Kneser, U., Lehnhardt, M., & Behr, B. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12677 · Cited by 17

Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells

Li, Z., Zhao, Y., Zhu, C., Katz, J., Michalek, S. M., Li, Y., & Zhang, P. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.07.004 · Cited by 17

Influence of age and gender on alveolar bone healing post tooth extraction in 129 Sv mice: a microtomographic, histological, and biochemical characterization

Biguetti, C. C., Chandrashekar, B. L., Simionato, G. B., Momesso, N. R., Duarte, M. A. H., Rodrigues, D. C., & Matsumoto, M. A. (2023) · Clinical Oral Investigations · doi:10.1007/s00784-023-05087-y · Cited by 17

Non-inflammatory destructive periodontal disease: a clinical, microbiological, immunological and genetic investigation

Repeke, C. E. P., Cardoso, C. R. D. B., Claudino, M., Silveira, E. M. V., Trombone, A. P. F., Campanelli, A. P., Silva, J. S., Júnior, W. M., & Garlet, G. P. (2012) · Journal of Applied Oral Science · doi:10.1590/s1678-77572012000100020 · Cited by 17

Biphasic anti-osteoclastic action of intravenous alendronate therapy in multiple myeloma bone disease

Kitano, M., Ogata, A., Sekiguchi, M., Hamano, T., & Sano, H. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0540-0 · Cited by 17

Caveolin-1 regulates osteoclast differentiation by suppressing cFms degradation

Lee, Y. D., Yoon, S., Ji, E., & Kim, H. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.77 · Cited by 18

Cepharanthine suppresses osteoclast formation by modulating the nuclear factor‐κB and nuclear factor of activated T‐cell signaling pathways

Lin, X., Song, F., Zhou, L., Wang, Z., Wei, C., Xu, J., Zhao, J., & Liu, Q. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27495 · Cited by 17

Sotrastaurin, a PKC inhibitor, attenuates RANKL‐induced bone resorption and attenuates osteochondral pathologies associated with the development of OA

Pang, C., Wen, L., Qin, H., Zhu, B., Lu, X., & Luo, S. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15404 · Cited by 18

The Inhibitory Role of Rab11b in Osteoclastogenesis through Triggering Lysosome-Induced Degradation of c-Fms and RANK Surface Receptors

Tran, M. T., Okusha, Y., Feng, Y., Morimatsu, M., Wei, P., Sogawa, C. A., Eguchi, T., Kadowaki, T., Sakai, E., Okamura, H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249352 · Cited by 17

Osteoclast: Origin and Differentiation

Rubin, J. E., & Greenfield, E. M. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_1 · Cited by 18

Temporal and Spatial Localization of Osteoclasts in Colonies from Embryonic Stem Cells

Hemmi, H., Okuyama, H., Yamane, T., Nishikawa, S., Nakano, T., Yamazaki, H., Kunisada, T., & Hayashi, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4153 · Cited by 17

The role of Toll-like receptor mediated signalling in the pathogenesis of multiple myeloma

Abdi, J., Engels, F., Garssen, J., & Redegeld, F. A. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.12.001 · Cited by 16

Poly-γ-glutamic acid suppresses osteoclastogenesis in human osteoclast precursors and prevents joint damage in a collagen-induced murine arthritis model

Lee, B., Jo, S., Kim, S.-M., Cho, M., Park, S., Youn, J., Ji, J. D., & Kim, T. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.09.004 · Cited by 16

Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL‐induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling

Yu, X., Li, K., Wang, Z., Fu, F., Shao, S., Song, F., Zhao, J., Chen, W., Liu, Q., & Xu, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28079 · Cited by 16

A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing c-Fos-NFATc1 Signaling Pathway

Tan, Y., Ke, M., Li, Z., Chen, Y., Zheng, J., Wang, Y., Zhou, X., Huang, G., & Li, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.753240 · Cited by 16

Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State

Senba, M., Kawai, K., & Mori, N. (2011) · Leukemia Research and Treatment · doi:10.1155/2012/128617 · Cited by 17

Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts

Choudhary, S., Goetjen, A., Estus, T., Jacome-Galarza, C. E., Aguila, H. L., Lorenzo, J. A., & Pilbeam, C. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686576 · Cited by 16

The biological role of interferon-inducible P204 protein in the development of the mononuclear phagocyte system

Roland, P. B. (2007) · Frontiers in bioscience · doi:10.2741/2728 · Cited by 16

HTLV-1 Infection and Its Associated Diseases

Saito, M., Jain, P., Tsukasaki, K., & Bangham, C. R. M. (2012) · Leukemia Research and Treatment · doi:10.1155/2012/123637 · Cited by 16

1,25-dihydroxyvitamin D3 inhibits directly human osteoclastogenesis by down-regulation of the c-Fms and RANK expression

Kim, T., Lee, B., Kwon, E., Choi, C. H., Sung, I., Kim, Y.-J., Sohn, J., & Ji, J. D. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.09.011 · Cited by 16

Molecular events in the jaw vascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases

Wang, R., Wang, H., Mu, J., Yuan, H., Pang, Y., Wang, Y., Du, Y., & Feng, H. (2023) · Journal of Biomedical Research · doi:10.7555/jbr.36.202200266 · Cited by 15

Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins

Blümke, A., Ijeoma, E., Simon, J., Wellington, R., Purwaningrum, M., Doulatov, S. R., Leber, E., Scatena, M., & Giachelli, C. M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03547-6 · Cited by 15

Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitors

Omar, I., Ram, G. G., Rahat, D., Tabach, Y., Berger, M., & Levaot, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-31428-z · Cited by 15

Circaea mollis Siebold & Zucc. Alleviates postmenopausal osteoporosis in a mouse model via the BMP-2/4/Runx2 pathway

Park, J., Son, Y., Lee, C. H., Nho, C. W., & Yoo, G. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02914-7 · Cited by 15

Estrogen Decreases Cytoskeletal Organization by Forming an ERα/SHP2/c-Src Complex in Osteoclasts to Protect against Ovariectomy-Induced Bone Loss in Mice

Park, H.-J., Gholam-Zadeh, M., Yoon, S.-Y., Suh, J., & Choi, H. (2021) · Antioxidants · doi:10.3390/antiox10040619 · Cited by 16

Inhibition of osteoclastogenesis by RNA interference targeting RANK

Ma, R., Xu, J., Dong, B., Kauther, M. D., Jäger, M., & Wedemeyer, C. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-154 · Cited by 15

(−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways

Hsiao, H.-B., Wu, J., & Lin, W. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1737-9 · Cited by 15

Substrate Microarchitecture Shapes the Paracrine Crosstalk of Stem Cells with Endothelial Cells and Osteoblasts

Martín-Saavedra, F., Crespo, L., Escudero-Duch, C., Saldaña, L., Gómez‐Barrena, E., & Vilaboa, N. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-15036-x · Cited by 15

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression

Kim, E.-J., Lee, H., Kim, M. H., & Yang, W. M. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2331-5 · Cited by 15

RANKL Induces Formation of Avian Osteoclasts from Macrophages but Not from Macrophage Polykaryons

Boissy, P., Destaing, O., & Jurdic, P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5787 · Cited by 15

Extracellular Vesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells Suppress RANKL-Induced Osteoclast Differentiation via miR122-5p

Choi, J., Sung, S., Kang, K., Lee, S., Sung, M. K., Park, W.-T., Kim, Y. I., Seo, M., & Lee, G. W. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10569-5 · Cited by 14

F4/80 inhibits osteoclast differentiation via downregulation of nuclear factor of activated T cells, cytoplasmic 1

Kang, J., Sim, J.-S., Zheng, T., & Yim, M. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0900-7 · Cited by 14

Biological Evaluation and Transcriptomic Analysis of Corylin as an Inhibitor of Osteoclast Differentiation

Yu, A. X., Xiao, J. R., Zhao, S., Kong, X., Kwan, K. K., Zheng, B. Z.-Y., Wu, K. Q., Dong, T. T.-X., & Tsim, K. W. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073540 · Cited by 14

Protocatechualdehyde inhibits receptor activator of nuclear factor kappa‐B ligand ‐induced osteoclastogenesis and attenuates lipopolysaccharide‐induced inflammatory osteolysis

Huang, H., Jiang, W., Hong, K., Cai, J., He, Y., Ma, X., Wu, P., Lang, J., Ma, Y., Huang, C., et al. (2021) · Phytotherapy Research · doi:10.1002/ptr.7088 · Cited by 14

Thiaplakortone B attenuates RANKL‐induced NF‐κB and MAPK signaling and dampens OVX‐induced bone loss in mice

Wang, Q., Chen, D., Wang, Y., Dong, C., Liu, J., Chen, K., Song, F., Wang, C., Yuan, J., Davis, R. A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113622 · Cited by 14

Influence of Pasteurella multocida Toxin on the differentiation of dendritic cells into osteoclasts.

Chakraborty, S., Kloos, B., Roetz, N., Schmidt, S., Eigenbrod, T., Kamitani, S., & Kubatzky, K. F. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.09.001 · Cited by 13

Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo

Li, Y., Chen, F., Liu, T., Cai, Z., Chen, K., Tang, G., Huang, J., Liu, X.-G., Huang, J., Wang, P., et al. (2020) · Stem Cells International · doi:10.1155/2020/8829212 · Cited by 14

Receptor Activator of Nuclear Factor-κB Is Induced by a Rottlerin-sensitive and p38 MAP Kinase-dependent Pathway during Monocyte Differentiation

Kang, H. S., Park, E. K., Kim, K., Park, J. Y., Choi, J., Shin, H., Jun, C., Kang, S., & Kim, S. (2004) · Molecules and Cells · doi:10.1016/s1016-8478(23)13064-0 · Cited by 14

The ATF3–OPG Axis Contributes to Bone Formation by Regulating the Differentiation of Osteoclasts, Osteoblasts, and Adipocytes

Kim, J. H., Kim, K., Kim, I., Seong, S., Koh, J., & Kim, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073500 · Cited by 13

Bub1 suppresses inflammatory arthritis–associated bone loss in mice through inhibition of TNFα–mediated osteoclastogenesis

Yoshida, S., Ikedo, A., Yanagihara, Y., Sakaue, T., Saeki, N., & Imai, Y. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae015 · Cited by 13

Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts

Kawamata, A., Inoue, A., Miyajima, D., Hemmi, H., Mashima, R., Hayata, T., Ezura, Y., Amagasa, T., Yamanashi, Y., & Noda, M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22909 · Cited by 13

Deguelin inhibits RANKL‐induced osteoclastogenesis in vitro and prevents inflammation‐mediated bone loss in vivo

Zhang, T., Zhao, K., Han, W., Yang, W., Lu, X., Liu, Q., Li, X., & Qian, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27087 · Cited by 13

Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer

Patil, K., & Soekmadji, C. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_12 · Cited by 14

A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: Enhanced transfection efficiency before and after differentiation

Amano, S., Sekine, K., Bonewald, L. F., & Ohmori, Y. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21827 · Cited by 13

The sphingosine‐1‐phosphate receptor 1 binding molecule FTY 720 inhibits osteoclast formation in rats with ligature‐induced periodontitis

Lee, D., Kim, J. ‐., Choi, S., Cha, J., Bak, E., & Yoo, Y. (2016) · Journal of Periodontal Research · doi:10.1111/jre.12366 · Cited by 13

Osteoporosis and Bone Biology

de Paula, F. J. A., Black, D. M., & Rosen, C. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00029-0 · Cited by 14

Epigenetic mechanisms of myeloid differentiation in the tumor microenvironment

Rodríguez‐Ubreva, J., García-Gómez, A., & Ballestar, E. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.04.008 · Cited by 13

Ninjurin1 positively regulates osteoclast development by enhancing the survival of prefusion osteoclasts

Bae, S., Shin, M. W., Son, T., Lee, H. S., Chae, J. S., Jeon, S., Oh, G. T., & Kim, K. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0201-3 · Cited by 14

Bone and the Immune System

Weitzmann, M. N. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-56192-9_12 · Cited by 13

Inhibition of differentiation and function of osteoclasts by dimethyl sulfoxide (DMSO)

Yang, C., Madhu, V., Thomas, C., Yang, X., Du, X., Dighe, A. S., & Cui, Q. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2245-1 · Cited by 13

Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells

Fan, X., Fan, D., Gewant, H. D., Royce, C. L., Nanes, M. S., & Rubin, J. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e103 · Cited by 13

Advances in Regenerative Therapies for Inflammatory Arthritis: Exploring the Potential of Mesenchymal Stem Cells and Extracellular Vesicles

Klyucherev, T. O., Peshkova, M., Yurkanova, M. D., Kosheleva, N. V., Svistunov, A. А., Liang, X., & Timashev, P. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125766 · Cited by 12

Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss

Ha, H., Shim, K., Kim, T. S., Lee, C.-J., Park, J. H., Kim, H. S., & Yeul, J. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-352 · Cited by 13

RANK- NFATc1 signaling forms positive feedback loop on rank gene expression via functional NFATc1 responsive element in rank gene promoter

Kitazawa, R., Haraguchi, R., Kohara, Y., & Kitazawa, S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.100 · Cited by 12

7-Ketocholesterol-Induced Micro-RNA-107-5p Increases Number and Activity of Osteoclasts by Targeting MKP1

Li, G., Sul, O., Yu, R., & Choi, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073697 · Cited by 12

Human circulating monocytes can express receptor activator of nuclear factor‐κB ligand and differentiate into functional osteoclasts without exogenous stimulation

Seta, N., Okazaki, Y., & Kuwana, M. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.4 · Cited by 12

Biomimetic materials for controlling bone cell responses

Drevelle, O. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s378 · Cited by 12

The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK

Ceglie, I. D., Blom, A. B., Davar, R., Logie, C., Martens, J. H. A., Habibi, E., Böttcher, L., Roth, J., Vogl, T., Goodyear, C. S., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802691rr · Cited by 12

Vitamin D Inhibition of TRPV5 Expression During Osteoclast Differentiation

Gu, J., Tong, X., Chen, Y., Zhang, C., Ma, T., Li, S., Min, W., Yuan, Y., Liu, X., Bian, J., et al. (2019) · Intern J Endocrinol Metab · doi:10.5812/ijem.91583 · Cited by 12

Cytochalasin Z11 inhibits RANKL-induced osteoclastogenesis via suppressing NFATc1 activation

Wang, L., Chen, K., He, J., Kenny, J., Yuan, Y. J., Chen, J., Liu, Q., Tan, R. X., Zhao, J., & Xu, J. (2019) · RSC Advances · doi:10.1039/c9ra07240c · Cited by 12

Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α

Wang, L., Qiu, X., Gui, Y., Xu, Y., Gober, H.-J., & Li, D. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s88512 · Cited by 12

Novel extraneural role of neurite outgrowth inhibitor A: Modulation of osteoclastogenesis via positive feedback regulation of nuclear factor of activated T cell cytoplasmic 1

Lee, Y., Kim, H. J., Park, C., Kim, W.-S., Lee, Z. H., & Kim, H. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1561 · Cited by 13

CD13 is a critical regulator of cell–cell fusion in osteoclastogenesis

Ghosh, M., Kelava, T., Vrhovac, I., Kalajzić, I., & Shapiro, L. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-90271-x · Cited by 12

Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.

Hayashi, S., Tsuneto, M., Yamada, T., Nose, M., Yoshino, M., Shultz, L., & Yamazaki, H. (2004) · Endocrinology · doi:10.1210/en.2004-0172 · Cited by 16

Circulating Osteoclast Precursors: A Mechanism and a Marker of Erosive Arthritis

Xing, L., & Schwarz, E. M. (2005) · Current Rheumatology Reviews · doi:10.2174/1573397052954127 · Cited by 12

Macrophages and osteoclasts: similarity and divergence between bone phagocytes

Halper, J., Dolfi, B., Ivanov, S., Madel, M., & Blin‐Wakkach, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1683872 · Cited by 12

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis

Castro, D. M., Lamana, A., Arribas‐Castaño, P., Gutiérrez‐Cañas, I., Villanueva‐Romero, R., Pérez‐García, S., Martínez, C., Juarranz, Y., de Córdoba‐Oñate, S. F., González‐Álvaro, I., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121880 · Cited by 11

Osteoimmunology research in rheumatoid arthritis: From single-cell omics approach

Hu, N., Wang, J., Ju, B., Li, Y., Fan, P., Jin, X., Kang, X., & Wu, S. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002678 · Cited by 11

NDR2 is critical for osteoclastogenesis by regulating ULK1-mediated mitophagy

Kong, X., Shan, Z., Zhao, Y., Tao, S., Chen, J., Ji, Z., Jin, J., Liu, J., Lin, W., Wang, X.-J., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.180409 · Cited by 11

Anti–NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice

Takami, K., Okamoto, K., Etani, Y., Hirao, M., Miyama, A., Okamura, G., Goshima, A., Miura, T., Kurihara, T., Fukuda, Y., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.171962 · Cited by 11

Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-α inhibits titanium particle-induced osteoclastogenesis and bone resorption

Guo, H., Zhang, J., HAO, S., & Jin, Q. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1416 · Cited by 11

Elevated Suppressor of Cytokine Signaling-1 (SOCS-1): A Mechanism for Dysregulated Osteoclastogenesis in HIV Transgenic Rats

Lafferty, M., Fantry, L., Bryant, J., Jones, O. D., Hammoud, D., Weitzmann, M., Lewis, G., Garzino-Demo, A., & Reid, W. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12117 · Cited by 12

Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells

Yang, T.-M., Sabokbar, A., Gibbons, C. L. M. H., & Athanasou, N. A. (2002) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.84b3.0840452 · Cited by 11

Cytotoxic Signal Transmission Pathways via TNF Family Receptors

Петрович, Б. И., Moshnikova, A., & Prusakova, O. V. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1014884400144 · Cited by 11

Inhibitory Effects of Combined Bone Morphogenetic Protein 2, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor on Osteoclast Differentiation and Activity

Wu, H. C., Yin, G., Pu, X., Wang, J., Liao, X., & Huang, Z. (2021) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0325 · Cited by 10

The Role of Jak/STAT Pathways in Osteoclast Differentiation

Lee, Y., & Kim, H. H. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.2.141 · Cited by 10

Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiation

Fuji, H., Ohmae, S., Noma, N., Takeiri, M., Yasutomi, H., Izumi, K., Ito, M., Toyomoto, M., Iwaki, S., Takemoto, K., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.153 · Cited by 10

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor

Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., & Suda, T. (1999)

Receptor Activator of NF₭B Ligand Stimulates the Differentiation of Osteoclast Progenitors of the Macrophage Lineage into Osteoclasts in the Presence of Macrophage Colony-Stimulating FactorPreprint

Pakan, P. (2017) · OSF Preprints (OSF Preprints) · doi:10.17605/osf.io/6pves

Macrophage Colony-Stimulating Factor (MCSF) and Receptor Activator of NF₭B Ligand (RANKL) in Osteoclastogenesis

Pakan, P. D., Alanazi, A. F. R., & Andronicos, N. M. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.131234 · Cited by 1

Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB

Cappellen, D., Luong-Nguyen, N.-H., Bongiovanni, S., Grenet, O., Wanke, C., & Šuša, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200434200 · Cited by 184

Bifurcation of osteoclasts and dendritic cells from common progenitors

Miyamoto, T. K., Ohneda, O., Arai, F., Iwamoto, K., Okada, S., Takagi, K., Anderson, D. M., & Suda, T. (2001) · Blood · doi:10.1182/blood.v98.8.2544 · Cited by 280